KRT18 and metabolic dysfunction-associated steatohepatitis: Furthermore, because circulating CK-18 levels have been shown to be non-invasive biomarkers for NAFLD/NASH and liver fibrosis prediction [40, 41], knowing whether AAA-1 could elicit fibrosis is under active investigations.